{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T04:04:30Z","timestamp":1779681870907,"version":"3.53.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","award":["EUDRACT 2018-001013-32"],"award-info":[{"award-number":["EUDRACT 2018-001013-32"]}],"id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","revespcardiol.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.rec.2025.12.008","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T16:15:05Z","timestamp":1765901705000},"page":"522-533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: 1-year results from the ADALA trial"],"prefix":"10.1016","volume":"79","author":[{"given":"Eduardo","family":"Flores-Umanzor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Cruz-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Cepas-Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavi","family":"Mill\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Ant\u00fanez-Mui\u00f1os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"Asmarats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Laffond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ander","family":"Regueiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"L\u00f3pez-Tejero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Hion Pedro","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sanchis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Rod\u00e9s-Cabau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dabit","family":"Arzamendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Freixa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2025.12.008_bib0150","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1747493019897870","article-title":"Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge","volume":"16","author":"Lippi","year":"2021","journal-title":"Int J Stroke."},{"key":"10.1016\/j.rec.2025.12.008_bib0155","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2025.12.008_bib0160","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2025.12.008_bib0165","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"January","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2025.12.008_bib0170","article-title":"Left Atrial Appendage Occlusion","volume":"1","author":"Alkhouli","year":"2022","journal-title":"JACC: Advances."},{"key":"10.1016\/j.rec.2025.12.008_bib0175","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jcin.2023.01.011","article-title":"SCAI\/HRS Expert Consensus Statement on Transcatheter Left Atrial Appendage Closure","volume":"16","author":"Saw","year":"2023","journal-title":"JACC Cardiovasc Interv."},{"key":"10.1016\/j.rec.2025.12.008_bib0180","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4244\/EIJ-D-21-01010","article-title":"Device-related thrombus following left atrial appendage occlusion","volume":"18","author":"Simard","year":"2022","journal-title":"EuroIntervention."},{"key":"10.1016\/j.rec.2025.12.008_bib0185","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jacc.2021.04.098","article-title":"Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion","volume":"78","author":"Simard","year":"2021","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2025.12.008_bib0190","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2022.02.047","article-title":"Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation","volume":"79","author":"Freeman","year":"2022","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2025.12.008_bib0195","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/CIRCULATIONAHA.121.054305","article-title":"Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease","volume":"144","author":"Calabr\u00f2","year":"2021","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2025.12.008_bib0200","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/eurheartj\/ehaa169","article-title":"Left atrial appendage occlusion with the Amplatzer\u2122 Amulet\u2122 device: full results of the prospective global observational study","volume":"41","author":"Hildick-Smith","year":"2020","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2025.12.008_bib0205","first-page":"142","article-title":"Low Dose of Direct Oral Anticoagulants after Left Atrial Appendage Occlusion","volume":"8","author":"Cepas-Guillen","year":"2021","journal-title":"J Cardiovasc Dev Dis."},{"key":"10.1016\/j.rec.2025.12.008_bib0210","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.jcin.2021.07.031","article-title":"Half-Dose Direct Oral Anticoagulation Versus Standard Antithrombotic Therapy After Left Atrial Appendage Occlusion","volume":"14","author":"Della Rocca","year":"2021","journal-title":"JACC Cardiovasc Interv."},{"key":"10.1016\/j.rec.2025.12.008_bib0215","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamacardio.2024.2335","article-title":"Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: The ADALA Randomized Clinical Trial","volume":"9","author":"Freixa","year":"2024","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.rec.2025.12.008_bib0220","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10840-020-00884-x","article-title":"Rationale and design of a randomized clinical trial to compare two antithrombotic strategies after left atrial appendage occlusion: double antiplatelet therapy vs apixaban (ADALA study)","volume":"59","author":"Flores-Umanzor","year":"2020","journal-title":"J Interv Card Electrophysiol."},{"key":"10.1016\/j.rec.2025.12.008_bib0225","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/europace\/euz258","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update","volume":"22","author":"Glikson","year":"2020","journal-title":"Europace."},{"key":"10.1016\/j.rec.2025.12.008_bib0230","first-page":"4","article-title":"Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies","volume":"19","author":"Tzikas","year":"2017","journal-title":"Europace."},{"key":"10.1016\/j.rec.2025.12.008_bib0235","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2025.12.008_bib0240","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008112","article-title":"Detection of Device-Related Thrombosis Following Left Atrial Appendage Occlusion: A Comparison Between Cardiac Computed Tomography and Transesophageal Echocardiography","volume":"12","author":"Korsholm","year":"2019","journal-title":"Circ Cardiovasc Interv."},{"key":"10.1016\/j.rec.2025.12.008_bib0245","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.4244\/EIJY14M09_18","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion","volume":"10","author":"Meier","year":"2015","journal-title":"EuroIntervention."},{"key":"10.1016\/j.rec.2025.12.008_bib0250","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1093\/eurheartj\/ehs255","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document","volume":"33","author":"Kappetein","year":"2012","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2025.12.008_bib0255","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.jacc.2023.08.010","article-title":"Network Meta-Analysis of Initial Antithrombotic Regimens After Left Atrial Appendage Occlusion","volume":"82","author":"Carvalho","year":"2023","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2025.12.008_bib0260","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.jcin.2021.07.031","article-title":"Half-Dose Direct Oral Anticoagulation Versus Standard Antithrombotic Therapy After Left Atrial Appendage Occlusion","volume":"14","author":"Della Rocca","year":"2021","journal-title":"JACC Cardiovasc Interv."},{"key":"10.1016\/j.rec.2025.12.008_bib0265","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.jcin.2024.05.032","article-title":"Early Nonprocedural Bleeding After Left Atrial Appendage Occlusion","volume":"17","author":"Mesnier","year":"2024","journal-title":"JACC Cardiovasc Interv."},{"key":"10.1016\/j.rec.2025.12.008_bib0270","doi-asserted-by":"crossref","first-page":"13802","DOI":"10.3390\/ijerph192113802","article-title":"Incidence and Predictors of Clinically Significant Bleedings after Transcatheter Left Atrial Appendage Closure","volume":"19","author":"Zieli\u0144ski","year":"2022","journal-title":"Int J Environ Res Public Health."},{"key":"10.1016\/j.rec.2025.12.008_bib0275","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/MCG.0000000000001796","article-title":"Safety of Direct Oral Anticoagulants for Gastrointestinal Hemorrhage in Patients With Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-analysis of Real-world Studies","volume":"57","author":"Archontakis Barakakis","year":"2023","journal-title":"J Clin Gastroenterol."},{"key":"10.1016\/j.rec.2025.12.008_bib0280","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1097\/MEG.0000000000002035","article-title":"Major gastrointestinal bleeding risk with direct oral anticoagulants: Does type and dose matter?- A systematic review and network meta-analysis","volume":"33","author":"Radadiya","year":"2021","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10.1016\/j.rec.2025.12.008_bib0285","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1056\/NEJMoa2509426","article-title":"Apixaban for Extended Treatment of Provoked Venous Thromboembolism","volume":"393","author":"Piazza","year":"2025","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2025.12.008_bib0290","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.carrev.2021.11.007","article-title":"Treatment of Device-Related Thrombosis After Left Atrial Appendage Occlusion: Initial Experience With Low-Dose Apixaban","volume":"40","author":"Flores-Umanzor","year":"2022","journal-title":"Cardiovasc Revasc Med."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585725003524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585725003524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T03:28:07Z","timestamp":1779679687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585725003524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1885585725003524"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2025.12.008","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: 1-year results from the ADALA trial","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2025.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2025.11.015","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Cardiolog\u00eda.","name":"copyright","label":"Copyright"}]}}